Quick Takeaways
- Et al Phillip Frost MD filed SCHEDULE 13D/A for Cocrystal Pharma, Inc. Common Stock, par value $0.001 per share (COCP).
- Disclosed ownership: 18%.
- Date of event: 28 Oct 2025.
Et al Phillip Frost MD - 28 Oct 2025 SCHEDULE 13D/A Report for Cocrystal Pharma, Inc. Common Stock, par value $0.001 per share (COCP)
- Filing Manager
- Et al Phillip Frost MD
- Reporting Manager
- Phillip Frost, M.D.
- Symbol
- COCP
- Shares outstanding
- 13,831,528 shares
- Disclosed Ownership
- 2,462,012 shares
- Ownership
- 18%
- Form type
- SCHEDULE 13D/A
- Filing time
- 30 Oct 2025, 16:42:20 UTC
- Date of event
- 28 Oct 2025
- Previous filing
- 02 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Et al Phillip Frost MD disclosed 18% ownership in Cocrystal Pharma, Inc. Common Stock, par value $0.001 per share (COCP) on 28 Oct 2025."
What Changed
- Previous schedule filing date: 02 Oct 2025.
- Current filing was accepted on 30 Oct 2025, 16:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Phillip Frost, M.D. | 18% | 2,462,012 | 1,694,794 | 0 | /s/ Phillip Frost, M.D. | Phillip Frost, M.D. | 0000898860 |
| Frost Gamma Investments Trust | 17% | 2,398,977 | 1,679,551 | 0 | /s/ Phillip Frost, M.D. | Phillip Frost, M.D., Trustee | 0001380896 |